✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹365 Cr.
P/E
38.02

Key Ratios

Market cap
Market cap
365 Cr
PE
PE
38.02
Prom Holding
Prom Holding
73.06 %
ROE (%)
ROE (%)
30.24
ROCE (%)
ROCE (%)
29.26
Div Yield (%)
Div Yield (%)
-
Sales
Sales
43.21 Cr
OPM (%)
OPM (%)
29.12 %
Debt to Equity
Debt to Equity
0.85

About

Yash Optics & Lens specializes in manufacturing and supplying a diverse range of spectacle/opt… Read more
Low
73
52W Range
High
149
  • Yash Optics & Lens
  • Hemant Surgical Inds
  • Nureca Ltd.

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

4 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Yash Optics & Lens Ltd. Business

Yash Optics & Lensis primarily engaged in the business of manufacturing, trading, distribution and supplying of comprehensive range of spectacle/optical lenses. It is offering from single vision lenses to advanced progressive lenses, customized progressive lenses to personalized progressives for professionals along with wide range of coatings. Its products are available across the entire range of price points enabling it to serve the entire gamut of customers from economy. The company manufactures the lenses based on order and prescription received from the customers.

Yash Optics & Lens major competitors are Hemant Surgical Inds, Nureca Ltd., Holmarc Opto-Mech, Raaj Medisafe India, Kretto Syscon, Shree Pacetronix, Amkay Products.
Market Cap of Yash Optics & Lens is ₹365 Crs.
While the median market cap of its peers are ₹99 Crs.

Yash Optics & Lens seems to be less financially stable compared to its competitors.
Altman Z score of Yash Optics & Lens is 9.19 and is ranked 4 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material